Guminski A, Foley P, Grob J-J, Robert C, Gutzmer R, Squittieri N, Kiecker F. Biochemistry laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.22];7(2):s181. Available from: https://jofskin.org/index.php/skin/article/view/2013